EXCLUSIVE: ETFs Vs. Mutual Funds — Why Main Management's Darol Ryan Expects Further Conversions In 2024
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 28 2024
0mins
Should l Buy BUYW?
Source: Benzinga
Smaller health care stocks have been undervalued, says Main Management exec.
"We have an overweight position there — not only in the major pharmaceuticals sector, but also the smaller biotechs."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BUYW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BUYW
Wall Street analysts forecast BUYW stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 14.340
Low
Averages
High
Current: 14.340
Low
Averages
High

No data
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
ETF Outflow Details: The Tradr 2X Long TLT Monthly ETF (TLTM) experienced the largest outflow, losing 20,000 units, which is a 40.0% decline in outstanding units compared to the previous week.
Author's Perspective: The opinions expressed in the article are solely those of the author and do not necessarily represent the views of Nasdaq, Inc.
See More
Smaller health care stocks have been undervalued, says Main Management exec.
"We have an overweight position there — not only in the major pharmaceuticals sector, but also the smaller biotechs."
See More



